Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Penn Medicine at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Penn Medicine brings 4 presentations to ASH 2026 in New Orleans, and exhibits at Booth 130. Its program spans myelofibrosis care, sickle cell trial design and CAR T-cell therapy. Work covers differences between academic and community myelofibrosis care and CD5-negative T-cell persistence.

OrganizationASH 2026 Attendance
Penn Medicine
Philadelphia, PA
Hospitals & cancer centres
University of Pennsylvania's academic health system; its Abramson Cancer Center provides cancer care across hospitals in Pennsylvania, New Jersey and Delaware.
Booth
Exhibiting at Booth 130
Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm
Session
Sun Dec 13
4:30pm–6:00pm
Real-World Data Applications in Sickle Cell Disease Trial Design
Using sickle cell disease registries and health records to build external control arms, track safety after approval, and define pain as a trial endpoint.
Red cells · AI & data

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Penn Medicine

Tell us what you sell and we’ll find the people at Penn Medicine most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction